GlobeNewsWire
03 Aug 2026, 21:38 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
A securities fraud class action lawsuit has been filed against ADMA Biologics alleging misrepresentations of financial condition, revenue recognition, and inventory distribution. — Allegations of financial reporting fraud and revenue misstatement typically trigger significant investor distrust and potential regulatory scrutiny.
-0.60The lawsuit claims that corrective disclosures have already occurred, leading to a substantial loss in shareholder value. — Confirms that the market has already reacted negatively to the underlying issues, suggesting a loss of confidence in current management's guidance.
-0.40Hagens Berman is actively recruiting whistleblowers with non-public information regarding ADMA's distribution channels and financial reporting. — The pursuit of internal whistleblowers increases the likelihood of discovering damaging evidence that could lead to higher legal settlements or SEC sanctions.
-0.30Continue reading
6 related stories
Top 1 mover · tap to explore
Which stocks this story touches
The company is facing a securities fraud class action lawsuit alleging misrepresentations of financial condition and business practices.
The article notes that investors lost money after the stock plunged due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
3h ago
